| RS1336106190 |
TMEM216
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome, Joubert syndrome 2 |
| RS1336108562 |
DICER1
|
Health Risk |
Conflicting classifications of pathogenicity |
DICER1-related tumor predisposition, Hereditary cancer-predisposing syndrome |
| RS1336115331 |
DYRK1A
|
Health Risk |
Conflicting classifications of pathogenicity |
DYRK1A-related intellectual disability syndrome, DYRK1A-related intellectual disability syndrome |
| RS1336117447 |
MCM3AP
|
Health Risk |
Pathogenic |
— |
| RS1336143561 |
LOX
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, familial thoracic 10 |
| RS1336146310 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS1336147749 |
MAP2K1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, RASopathy |
| RS1336164502 |
TRMU
|
Health Risk |
Likely pathogenic |
Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins, Aminoglycoside-induced deafness |
| RS1336171284 |
GNRH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypogonadotropic hypogonadism 12 with or without anosmia, Hypogonadotropic hypogonadism |
| RS1336175305 |
ADAMTS2
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, dermatosparaxis type |
| RS1336176104 |
GNPTG
|
Health Risk |
Pathogenic |
GNPTG-mucolipidosis, GNPTG-mucolipidosis |
| RS1336177262 |
OCRL
|
Health Risk |
Conflicting classifications of pathogenicity |
Lowe syndrome, Lowe syndrome |
| RS1336208372 |
CCDC40
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1336214631 |
HPS3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS1336228562 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Hereditary cancer-predisposing syndrome |
| RS1336228861 |
ARID1A
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1336232266 |
TAP1
|
Health Risk |
Pathogenic |
MHC class I deficiency, Glioma susceptibility 1 |
| RS1336253157 |
CRB1
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1336260427 |
ARSA
|
Health Risk |
Conflicting classifications of pathogenicity |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS1336274191 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1336307815 |
STRC
|
Health Risk |
Likely pathogenic |
Rare genetic deafness, STRC-related disorder |
| RS1336317768 |
AHI1
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome, Retinal dystrophy |
| RS1336339961 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1336343565 |
RAG2
|
Health Risk |
Likely pathogenic |
— |
| RS1336350265 |
CNTN6
|
Health Risk |
Likely pathogenic |
Autism spectrum disorder, Autism spectrum disorder |
| RS1336354545 |
PTH1R
|
Health Risk |
Conflicting classifications of pathogenicity |
Connective tissue disorder, Connective tissue disorder |
| RS1336355924 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1336382616 |
ACSF3
|
Health Risk |
Likely pathogenic |
Combined malonic and methylmalonic acidemia, Combined malonic and methylmalonic acidemia |
| RS1336387628 |
TGFB1
|
Health Risk |
Likely pathogenic |
Encephalopathy, IL10-related early-onset inflammatory bowel disease |
| RS1336390351 |
EZH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Weaver syndrome, Inborn genetic diseases |
| RS1336395181 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1336396788 |
DSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Familial isolated arrhythmogenic right ventricular dysplasia |
| RS1336441841 |
SLC27A4
|
Health Risk |
Pathogenic |
— |
| RS1336481358 |
GLE1
|
Health Risk |
Pathogenic |
Lethal arthrogryposis-anterior horn cell disease syndrome, Lethal arthrogryposis-anterior horn cell disease syndrome |
| RS1336484333 |
DDB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Xeroderma pigmentosum, group E |
| RS1336507340 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, Early-infantile DEE |
| RS1336513210 |
ADAMTSL4
|
Health Risk |
Pathogenic |
— |
| RS1336552092 |
HSPG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Schwartz-Jampel syndrome, Schwartz-Jampel syndrome type 1 |
| RS1336558090 |
TSC2
|
Health Risk |
Likely pathogenic |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1336566500 |
FCHO1
|
Health Risk |
Pathogenic |
Severe congenital neutropenia, Immunodeficiency with T and B cell lymphopenia |
| RS1336571464 |
SAMHD1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS1336573328 |
CLTC
|
Health Risk |
Likely pathogenic |
— |
| RS1336584572 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1336602322 |
COL7A1
|
Health Risk |
Pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS1336603960 |
ALDH3A2
|
Health Risk |
Pathogenic |
Sjögren-Larsson syndrome, Sjögren-Larsson syndrome |
| RS1336618986 |
UNC80
|
Health Risk |
Pathogenic |
— |
| RS1336620798 |
TTC7A
|
Health Risk |
Pathogenic |
Multiple gastrointestinal atresias, Multiple gastrointestinal atresias |
| RS1336624126 |
MARVELD2
|
Health Risk |
Pathogenic |
— |
| RS1336636537 |
BBS4
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 4 |
| RS1336642579 |
SLC26A4
|
Health Risk |
Likely pathogenic |
— |
| RS1336644939 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic fibrosis, Cystic fibrosis |
| RS1336651679 |
CDAN1
|
Health Risk |
Pathogenic |
Anemia, congenital dyserythropoietic |
| RS1336652138 |
CHEK2
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS1336670524 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS1336685414 |
VARS1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with microcephaly, seizures |
| RS1336686272 |
COL7A1
|
Health Risk |
Pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS1336686317 |
RAG2
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency with skin granulomas, Combined immunodeficiency with skin granulomas |
| RS1336690304 |
AIPL1
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 4, AIPL1-related retinopathy |
| RS1336696568 |
ASAH1
|
Health Risk |
Pathogenic |
Farber lipogranulomatosis, Farber lipogranulomatosis |
| RS1336726861 |
GALC
|
Health Risk |
Pathogenic |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS1336732262 |
ALG1
|
Health Risk |
Likely pathogenic |
ALG1-congenital disorder of glycosylation, ALG1-congenital disorder of glycosylation |
| RS1336741146 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1336749001 |
CTSF
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS1336771064 |
ALOX12B
|
Health Risk |
Likely pathogenic |
Lamellar ichthyosis, Lamellar ichthyosis |
| RS1336782801 |
USP9X
|
Health Risk |
Pathogenic |
— |
| RS1336789467 |
ROR2
|
Health Risk |
Likely pathogenic |
Autosomal recessive Robinow syndrome, Autosomal recessive Robinow syndrome |
| RS1336792481 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Hypertrophic cardiomyopathy |
| RS1336799362 |
FCSK
|
Health Risk |
Likely pathogenic |
Congenital disorder of glycosylation with defective fucosylation 2, Congenital disorder of glycosylation with defective fucosylation 2 |
| RS1336799721 |
NAGA
|
Health Risk |
Pathogenic |
Alpha-N-acetylgalactosaminidase deficiency type 1, Alpha-N-acetylgalactosaminidase deficiency type 1 |
| RS1336819076 |
SDHAF2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary pheochromocytoma and paraganglioma, Pheochromocytoma/paraganglioma syndrome 2 |
| RS1336824977 |
BARD1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS1336828226 |
SLC13A5
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1336834251 |
FANCA
|
Health Risk |
Pathogenic/Likely pathogenic |
FANCA-related disorder, Fanconi anemia |
| RS1336842896 |
ERCC6L2
|
Health Risk |
Pathogenic |
— |
| RS1336849921 |
SPTAN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 5 |
| RS1336850278 |
DVL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1336906464 |
TREX1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 1, Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations |
| RS1336910973 |
ALOX12B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1336921050 |
CDH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary diffuse gastric adenocarcinoma |
| RS1336935881 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1336937886 |
CSRP3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 12, Dilated cardiomyopathy 1M |
| RS1336978749 |
NPHP1
|
Health Risk |
Likely pathogenic |
Joubert syndrome with renal defect, Joubert syndrome with renal defect |
| RS1337002578 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS1337014971 |
NMNAT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 9, Leber congenital amaurosis 9 |
| RS1337017523 |
LZTR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS1337018128 |
RNASEH2B
|
Health Risk |
Pathogenic |
Aicardi Goutieres syndrome, Aicardi Goutieres syndrome |
| RS1337022607 |
PKD1
|
Health Risk |
Pathogenic |
— |
| RS1337062385 |
TSEN54
|
Health Risk |
Pathogenic |
— |
| RS1337070499 |
TRIM37
|
Health Risk |
Pathogenic |
— |
| RS1337097412 |
ALS2
|
Health Risk |
Pathogenic |
Infantile-onset ascending hereditary spastic paralysis, Infantile-onset ascending hereditary spastic paralysis |
| RS1337097694 |
PEX5
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder due to PEX5 defect, Peroxisome biogenesis disorder due to PEX5 defect |
| RS1337113054 |
MYBPC3
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1337146202 |
CEP290
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS1337149388 |
TERT
|
Health Risk |
Conflicting classifications of pathogenicity |
Idiopathic Pulmonary Fibrosis, Dyskeratosis congenita |
| RS1337159250 |
TH
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive DOPA responsive dystonia, Autosomal recessive DOPA responsive dystonia |
| RS1337182136 |
CPS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital hyperammonemia, type I |
| RS1337186041 |
PANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Pigmentary pallidal degeneration, Pigmentary pallidal degeneration |
| RS1337201010 |
MCCC1
|
Health Risk |
Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, 3-methylcrotonyl-CoA carboxylase 1 deficiency |
| RS1337206941 |
JAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Isolated Nonsyndromic Congenital Heart Disease, Alagille syndrome due to a JAG1 point mutation |
| RS1337215414 |
MAN2B1
|
Health Risk |
Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |